Portable device for quantitative measurement of tissue autoregulation and neurovascular coupling using EEG, metabolism, and blood flow diagnostics

Patent metadata

Field	Value
Publication number	US-12213770-B2
Application number	US-202117377123-A
Country	US
Kind code	B2
Filing date	Jul 15, 2021
Priority date	Apr 1, 2019
Publication date	Feb 4, 2025
Grant date	Feb 4, 2025

Abstract

A portable device for quantitative measurement of tissue autoregulation and neurovascular coupling via portable measurement of blood flow, oxygenation, metabolism, and/or EEG signals and methods for using said device. The device may comprise a body and a plurality of legs pivotably attached to the body. The plurality of legs may comprise at least one reference electrode leg and at least one measurement electrode leg for electrical measurement, and an optical detection fiber leg and at least one optical source fiber leg for optical blood flow, oxygenation, and metabolism measurement. The present invention is additionally directed to a portable device for blood flow measurement and therapeutic photobiomodulation. The device may comprise a body and a plurality of legs. The plurality of legs may comprise at least one optical detection fiber leg and at least one optical source fiber leg, and at least one leg for therapeutic photobiomodulation.

First claim

What is claimed is:

1. A non-invasive method of determining a depth-calibrated absolute value of cerebral metabolic rate of oxygen (CMRO 2 ) using optical measurement of tissue perfusion, absorption, and scattering, the method comprising:
a. positioning one or more light sources and two or more detectors in proximity to a cerebral tissue of a subject;
b. emitting a coherent light signal from one or more of the light sources into the head, such that that one or more backscattered light signals are generated;
c. detecting one or more of the backscattered light signals via the two or more detectors;
d. determining a dynamic perfusion metric, a tissue absorption coefficient, and a tissue scattering coefficient from the detected signals;
e. determining a mean penetration depth of the detected signals, using the tissue absorption coefficient and tissue scattering coefficient; and
f. determining an absolute value of CMRO 2 using the mean penetration depth, the dynamic perfusion metric, the tissue absorption coefficient, and the tissue scattering coefficient;
wherein absolute value of CMRO 2 is depth-calibrated using the mean penetration depth, and
wherein the dynamic perfusion metric, the tissue absorption coefficient, and the tissue scattering coefficient provide all the information necessary to calculate the depth-calibrated absolute value of CMRO 2 .

2. The method of claim 1 , additionally comprising modifying the light emission or detection to change the mean penetration depth, and calculating a depth-calibrated absolute value of CMRO 2 at each mean penetration depth.

3. The method of claim 2 , wherein the mean penetration depth is changed by adjusting one or more source-detector separation distances, a modulation frequency or wavelength of the coherent light signal, or a combination thereof.

4. The method of claim 1 , additionally comprising determining one or more fluid metrics from the detected signals.

5. The method of claim 4 , wherein the fluid metrics are indicative of a degree of swelling or edema of the tissue.

6. The method of claim 4 , wherein the fluid metrics comprise a parameter of cellular components of the tissue.

7. The method of claim 6 , wherein the parameter of cellular components of the tissue comprises a shape, a size, or a refractive index of the cellular components.

8. The method of claim 1 , wherein separate values of CMRO 2 are calculated using a diffuse flow calibrated perfusion metric and a directed flow calibrated perfusion metric.

9. The method of claim 1 , wherein the absolute value of CMRO 2 is corrected to account for an effect of a geometry or arrangement of the light sources and detectors.

10. The method of claim 1 , additionally comprising dividing the absolute value of CMRO 2 by the calibrated perfusion metric to determine a depth-calibrated value of cerebral autoregulation.

Assignees

• Univ California

Inventors

• Akbari Yama
• Wilson Robert H
• Crouzet Christian
• Milner Thomas
• Choi Bernard

Classifications

• A61B5/37

  Intracranial electroencephalography [IC-EEG], e.g. electrocorticography [ECoG] · CPC title

• A61B5/14553

  specially adapted for cerebral tissue · CPC title

• A61B5/0075

  by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy (A61B5/0071 takes precedence) · CPC title

• A61B5/6801

  specially adapted to be attached to or worn on the body surface · CPC title

• A61N2005/0644

  Handheld applicators · CPC title